The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review.
cost of illness
health care costs
indirect costs
mania
mood disorder
resource utilization
Journal
ClinicoEconomics and outcomes research : CEOR
ISSN: 1178-6981
Titre abrégé: Clinicoecon Outcomes Res
Pays: New Zealand
ID NLM: 101560564
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
05
2020
accepted:
12
08
2020
entrez:
28
9
2020
pubmed:
29
9
2020
medline:
29
9
2020
Statut:
epublish
Résumé
Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania, hypomania, and/or depression. BD is associated with substantial economic burden, and the bipolar I disorder (BD-I) subtype is associated with high medical costs. This review further evaluated the economic burden of BD and BD-I in the United States (US), describing health-care resource utilization (HCRU) and sources of direct medical and indirect costs. Data were obtained from systematic searches of MEDLINE
Identifiants
pubmed: 32982338
doi: 10.2147/CEOR.S259338
pii: 259338
pmc: PMC7489939
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
481-497Informations de copyright
© 2020 Bessonova et al.
Déclaration de conflit d'intérêts
Leona Bessonova, Michael J. Doane, and Amy K. O’Sullivan are employees of Alkermes, Inc. and may own stock/options in the company. Kristine Ogden is an employee of Worldwide Clinical Trials, Inc., which has received consulting fees from Alkermes, Inc. for conducting this study. Mauricio Tohen was an employee of Lilly (1997 to 2008) and has received honoraria from or consulted for Abbott, AstraZeneca, Alkermes, Allergan, Bristol-Myers Squibb, GlaxoSmithKline, Lilly, Johnson & Johnson, Otsuka, Merck, Gedeon Richter Plc, Sunovion, Forest, Roche, Elan, Lundbeck, Teva, Pamlab, Minerva, Neurocrine, Pfizer, Wyeth and Wiley Publishing. The authors report no other conflicts of interest in this work.
Références
Am J Psychiatry. 2013 Feb;170(2):180-7
pubmed: 23377639
Psychiatr Serv. 2012 Jul;63(7):666-71
pubmed: 22588167
Clin Pract Epidemiol Ment Health. 2009 Jan 23;5:3
pubmed: 19166608
J Nerv Ment Dis. 2016 Feb;204(2):87-94
pubmed: 26588078
J Med Econ. 2011;14(2):217-26
pubmed: 21370989
Value Health. 2010 Dec;13(8):984-8
pubmed: 20667057
J Med Econ. 2009 Jun;12(2):104-13
pubmed: 19527195
Curr Med Res Opin. 2009 Feb;25(2):351-61
pubmed: 19192979
J Clin Psychiatry. 2010 Mar;71(3):296-303
pubmed: 20331931
Arch Gen Psychiatry. 2007 May;64(5):543-52
pubmed: 17485606
Ann Gen Psychiatry. 2009 Feb 18;8:7
pubmed: 19226463
Am J Psychiatry. 2013 Mar;170(3):265-74
pubmed: 23361837
Aust N Z J Psychiatry. 2015 Dec;49(12):1087-206
pubmed: 26643054
Bipolar Disord. 2011 Jun;13(4):387-95
pubmed: 21843278
J Clin Psychopharmacol. 2009 Dec;29(6):595-600
pubmed: 19910727
Psychiatr Serv. 2011 Sep;62(9):1032-40
pubmed: 21885581
J Ment Health Policy Econ. 2010 Jun;13(2):87-92
pubmed: 20919595
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
J Soc Work Disabil Rehabil. 2014;13(1-2):31-43
pubmed: 24483783
Harv Rev Psychiatry. 2014 Nov-Dec;22(6):363-6
pubmed: 25377611
Int J Bipolar Disord. 2013 Aug 23;1:12
pubmed: 25505679
J Clin Psychiatry. 2017 Jan;78(1):129-137
pubmed: 27780336
Mayo Clin Proc. 2017 Oct;92(10):1532-1551
pubmed: 28888714
J Med Econ. 2010;13(3):552-8
pubmed: 20795792
Bipolar Disord. 2012 May;14(3):271-82
pubmed: 22548900
Int J Neuropsychopharmacol. 2017 Feb 1;20(2):180-195
pubmed: 27941079
Gerontologist. 2013 Apr;53(2):334-44
pubmed: 23275518
Psychiatr Serv. 2015 Sep;66(9):907-9
pubmed: 25975893
Arch Gen Psychiatry. 2005 Dec;62(12):1322-30
pubmed: 16330720
Psychiatr Serv. 2011 Sep;62(9):1073-8
pubmed: 21885587
BMC Psychiatry. 2010 Jun 04;10:39
pubmed: 20525372
J Clin Psychiatry. 2008 May;69(5):749-58
pubmed: 18363423
Ann Gen Psychiatry. 2017 Feb 10;16:9
pubmed: 28203265
J Psychiatr Res. 2017 Jan;84:310-317
pubmed: 27814503
Pharmacoeconomics. 2001;19(5 Pt 1):483-95
pubmed: 11465308
J Affect Disord. 2018 Jan 15;226:45-51
pubmed: 28961441
Am J Health Syst Pharm. 2009 Feb 15;66(4):358-65
pubmed: 19202045
Hum Psychopharmacol. 2008 Mar;23(2):95-105
pubmed: 18058849
World J Biol Psychiatry. 2018 Feb;19(1):2-58
pubmed: 29098925
Appl Health Econ Health Policy. 2010;8(3):167-77
pubmed: 20408601
Bipolar Disord. 2008 Sep;10(6):718-25
pubmed: 18837866
Soc Psychiatry Psychiatr Epidemiol. 1995 Aug;30(5):213-9
pubmed: 7482006
Clin Ther. 2008 Jul;30(7):1358-74
pubmed: 18691997
J Clin Psychiatry. 2016 Jul;77(7):920-6
pubmed: 26580001
J Med Econ. 2010 Mar;13(1):23-32
pubmed: 19961361
Am J Psychiatry. 2020 Aug 1;177(8):706-715
pubmed: 32312111
Am J Manag Care. 2014 Feb 01;20(2):e52-60
pubmed: 24738555
J Psychopharmacol. 2016 Jun;30(6):495-553
pubmed: 26979387
Value Health. 2008 May-Jun;11(3):416-23
pubmed: 18179673
J Affect Disord. 2011 Mar;129(1-3):79-83
pubmed: 20888048
J Clin Psychiatry. 2011 Feb;72(2):240-7
pubmed: 20868629
Prim Care Companion CNS Disord. 2017 Jun 1;19(3):
pubmed: 28590601
BMC Psychiatry. 2011 Jan 07;11:6
pubmed: 21214937
J Med Econ. 2010;13(4):698-704
pubmed: 21073403
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
J Nerv Ment Dis. 2014 Apr;202(4):271-4
pubmed: 24647219
Pharmacoeconomics. 2015 Apr;33(4):341-53
pubmed: 25576148
Bipolar Disord. 2010 Jun;12(4):404-13
pubmed: 20636638
Curr Psychiatry Rep. 2012 Dec;14(6):687-95
pubmed: 23001382
Nat Rev Dis Primers. 2018 Mar 08;4:18008
pubmed: 29516993
Bipolar Disord. 2009 Dec;11(8):876-84
pubmed: 19922556
Adm Policy Ment Health. 2012 May;39(3):200-9
pubmed: 21533848
Psychiatr Serv. 2010 May;61(5):516-9
pubmed: 20439375
Psychiatr Serv. 2019 Apr 1;70(4):353
pubmed: 30929615
Health Qual Life Outcomes. 2011 Oct 13;9:90
pubmed: 21995725
Psychiatr Serv. 2008 Oct;59(10):1175-83
pubmed: 18832504
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
J Manag Care Spec Pharm. 2016 Nov;22(11):1330-1336
pubmed: 27783555
BMJ Open. 2013 Apr 18;3(4):
pubmed: 23604348
Bipolar Disord. 2014 Jun;16(4):337-53
pubmed: 24372893
P T. 2008 Jan;33(1):15-34
pubmed: 19749991
Clin Ther. 2011 Oct;33(10):1381-1390.e4
pubmed: 22000656
J Affect Disord. 2017 Jun;215:135-142
pubmed: 28319690
J Occup Environ Med. 2010 May;52(5):478-85
pubmed: 20431414